somatic mutations in mds as a diagnostic and prognostic tool
Published 5 years ago • 115 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
2:08
somatic mutations in mds as targets for therapy
-
3:58
prognosis & advances in treatment strategies for sf3b1-mutant mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
0:55
the role of rna modifications in mds and aml
-
1:23
immunological impact of tp53 in mds
-
2:14
trial updates for luspatercept in lr-mds: commands, medalist and elements-mds
-
1:34
feasibility of the ipss-m in cmml
-
0:55
the use of ngs to better risk stratify patients & identify druggable mutations in mds
-
1:17
exciting novel treatments being developed for mds
-
2:34
the role of ezh2 mutations in mds
-
4:39
aml & mds: mac or ric?
-
2:00
an update on the genomic landscape of mm
-
1:13
enasidenib for idh2-mutated mds
-
2:12
social media – a useful tool for hematological research
-
10:18
classification of high-risk mutations in mds
-
6:39
molecular techniques for monitoring mrd in aml
-
1:52
an update on the use of navtemadlin in myelofibrosis
-
3:29
novel drugs and targets in mds